Aurobindo Pharma arm gets USFDA nod with EIR for Andhra Pradesh facility
Aurobindo Pharma’s step-down subsidiary, Eugia Sterlite, has received an Establishment Inspection Report (EIR) from the USFDA for its new injectable facility in Andhra Pradesh. The report follows an inspection conducted between March 28 and April 5, 2024.